Production Operator at Acadia Pharmaceuticals

Glasgow, Scotland, United Kingdom

Acadia Pharmaceuticals Logo
Not SpecifiedCompensation
Entry Level & New Grad, Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biopharmaceuticals, Reproductive Medicine, Maternal HealthIndustries

Requirements

  • Excellent attention to detail and accuracy in data recording
  • Ability to follow written instructions
  • Good organisational skills and ability to meet deadlines
  • Effective team player
  • Quality mindset
  • Experience in a regulated environment preferred (full training provided if lacking)

Responsibilities

  • Participate in all aspects of manufacturing process operations
  • Understand and apply Production and Quality procedures
  • Respect and lead the Safety, Health and Environment Policy rules
  • Participate in improvement initiatives to increase efficiency of work processes

Skills

manufacturing process operations
production procedures
quality procedures
safety health environment policy
attention to detail
data recording
follow instructions
organisational skills
teamwork
quality mindset
regulated environment

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters
1993Year Founded
$813.4MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Paid Vacation
Paid Holidays
Paid Sick Leave
Paid Parental Leave
Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.
Potential clinical trial delays could affect drug approval timelines.
Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
The company has a strong R&D foundation, developing innovative small molecule drugs.
Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI